Sunday, March 31, 2013

More Details Emerge On Shanghai H7N9 Case

 

image

Site of recent H7N9 infections

 

# 7046

 

A few more details are beginning to emerge regarding  at least one of the fatal H7N9 cases in Shanghai (see China: Two Deaths From H7N9 Avian Flu).

 

The two identified cases are an 87-year-old (Li) who fell ill on February 19 and died on March 4, and a 27-year-old (Wu) who fell ill on February 27 and died on March 10.

 

At the time, two sons in the Li family were also hospitalized with similar symptoms. One died, while the other one recovered. 

 

FluTrackers  carried the story back on March 8th.

 

SARS ruled out in death cases


By Cai Wenjun | 2013-3-8
HEALTH authorities have ruled out SARS, bird flu or a new SARS-like virus in the deaths of two people from the same family at Shanghai No. 5 People's Hospital.

 

The hospital said three members of the Li family had been admitted between February 14 and 24 for symptoms including a high fever and coughing.
All three, aged 55, 69 and 87, were diagnosed as having pneumonia.

 

Since they were from the same family, the hospital reported the case to the Minhang District Center for Disease Control and Prevention for investigation. The pneumonia diagnosis was confirmed.

 

 

Now we learn that the 87 year-old in the above story is one of the two men that have tested positive for H7N9 in Shanghai.

 

While suspicious, there are no confirmatory lab tests on the other family members, so they are not currently considered as part of this cluster.

 

This from the Shanghai Daily.

 

New bird flu strain kills 2 patients in Shanghai

By Cai Wenjun 

TWO men suffering from a lesser-known type of bird flu have died in Shanghai and a woman in eastern Anhui Province is in a critical condition, health authorities said yesterday.


The three cases of H7N9 avian influenza infection are the first time the virus has been detected in humans, the National Health and Family Planning Commission said yesterday.


<SNIP>

The 87-year-old's two sons have gone to hospital with similar symptoms.

 

According to Shanghai No. 5 People's Hospital, the three members of the Li family were admitted between February 14 and 24 for symptoms including a high fever and coughing.

 

All three were diagnosed as having pneumonia.

 

The 69-year-old son recovered and was discharged but the 55-year-old died from severe pneumonia and respiratory failure in late February. The father died of multi-organ failure.

 

Neither son had the H7N9 virus, the bureau said.


It has ordered local hospitals to step up monitoring and supervision on cases involving flu, pneumonia and other respiratory diseases.

 

Experts say there is no evidence to indicate the virus is spreading but patients with symptoms such as fever, coughing and breathing difficulties are being urged to visit their doctors, ensure good hygiene, such as by washing their hands, and avoid contact with diseased poultry and livestock.

A Brief History Of H7 Avian Flu Infections

 

image

Site of recent H7N9 infections

 


# 7044

 

While it is far too soon to know if the breaking story out of Shanghai overnight (see China: Two Deaths From H7N9 Avian Flu) will have `legs’, the news of an H7 strain causing serious illness in humans is of some note.

 

In the past, when other H7 strains have been identified jumping to humans, they’ve generally only caused mild illness. 

 

Often little more than conjunctivitis. 

 

Ten years ago, the largest known H7 cluster was recorded in the Netherlands. In that outbreak, the culprit was H7N7.

 

Details on this cluster are reported in the December 2005 issue of the Eurosurveillance Journal.

 

Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003

M Du Ry van Beest Holle, A Meijer, M Koopmans3 CM de Jager, EEHM van de Kamp, B Wilbrink, MAE. Conyn-van Spaendonck, A Bosman

An outbreak of highly pathogenic avian influenza A virus subtype H7N7 began in poultry farms in the Netherlands in 2003. Virus infection was detected by RT-PCR in 86 poultry workers and three household contacts of PCR-positive poultry workers, mainly associated with conjunctivitis.

 

Roughly 30 million birds residing on more than 1,000 farms were culled to control the outbreak. One person - a veterinarian who visited an infected farm – died a week later of respiratory failure.

 

The rest of the symptomatic cases were relatively mild.

 

The Fraser Valley H7N3 outbreak of 2004 resulted in at least two human infections, as reported in this EID Journal report:

 

Human Illness from Avian Influenza H7N3, British Columbia

Abstract

Avian influenza that infects poultry in close proximity to humans is a concern because of its pandemic potential. In 2004, an outbreak of highly pathogenic avian influenza H7N3 occurred in poultry in British Columbia, Canada. Surveillance identified two persons with confirmed avian influenza infection. Symptoms included conjunctivitis and mild influenzalike illness.

 

More recently, in Mexico we saw two mild human cases last summer (see see MMWR: Mild H7N3 Infections In Two Poultry Workers - Jalisco, Mexico).  The World Health Organization published this Summary and assessment as of 10 September 2012.

 

Sporadic human cases of influenza A(H7N3) virus infection linked with outbreaks in poultry have been reported previously in Canada, Italy and the UK, with H7N2 in US and the UK, and with H7N7 in the UK and the Netherlands. Most H7 infections in humans have been mild with the exception of one fatal case in the Netherlands, in a veterinarian who had close contact with infected birds.

 

While global surveillance and reporting on novel avian viruses in humans is spotty at best, some other known H7 cases include:

image

    Chart lifted and edited from CIDRAP’s excellent overview Avian Influenza (Bird Flu): Implications for Human Disease  showing known H7 avian flu infections in humans over the two decades.

     

    Of course – H7 flu strains - like all influenza viruses, are constantly mutating and evolving. What is mild, or relatively benign today, may not always remain so.

     

    In 2008 we saw a study in  PNAS that suggested the H7 virus might just be inching its way towards better adaptation to humans (see Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility).

     

    You can read more about this in a couple of blogs from 2008, H7's Coming Out Party and H7 Study Available Online At PNAS.

     

    Among the avian influenzas, H5N1 virus gets the bulk of the headlines, due to its high fatality rate. While a matter of some controversy (see Revisiting The H5N1 CFR Debate), among known human cases, the mortality rate has been a staggering 60%.

     

    Other strains that have demonstrated at least some ability to infect humans include H7, H9, H10, and H11.

     

    Currently, H5s and H7s are both reportable diseases (to the OIE) in poultry, due to their ability to mutate from a low pathogenic virus to highly pathogenic virus.

     

    But up until now, their ability to spark serious illness in humans has been limited. Which makes China’s announcement of 3 human infections - all resulting in serious and/or fatal illness - of particular interest.

     

    We will obviously be following the H7N9 story with interest. Whether this story has significant public health implications is something we may not know for some time.

     


    A final note - proving that timing is everything - a couple of weeks ago, in EID Journal: Predicting Hotspots for Influenza Virus Reassortment, we saw a study that looked at those areas around the world with the greatest potential of spawning new flu strains. 

     

    The Shanghai region was one of those areas identified.

     

    Potential geographic foci of reassortment include the northern plains of India, coastal and central provinces of China, the western Korean Peninsula and southwestern Japan in Asia, and the Nile Delta in Egypt.

    image

    China: Two Deaths From H7N9 Avian Flu

    image

    UPDATE:  I’ve now posted a A Brief History Of H7 Avian Flu Infections


    # 7043

     

    An unusual story has emerged overnight out of China, where two people who died recently in Shanghai have been diagnosed with the avian H7N9 virus – the first time this normally low pathogenic avian has been known to jump to humans. 


    A third case, in Anhui Province, is reportedly in critical condition.  Thus far, no epidemiological links are apparent between these cases.

     

    Two stories:  First the Xinhua News account, followed by Hong Kong’s CHP announcement.

     

     

    Two Chinese die from H7N9 bird flu

    English.news.cn   2013-03-31 13:50:18

    BEIJING, March 31 (Xinhua) -- Three cases of human infection with H7N9 avian influenza have been detected recently in Shanghai and Anhui Province, and two of them have died, the other being in a critical condition, the National Health and Family Planning Commission said Sunday.

     

    The victims include an 87-year-old male in Shanghai who got sick on Feb. 19 and died on March 4, a 27-year-old male in Shanghai who became ill on Feb. 27 and died on March 10, and a 35-year-old female in Chuzhou City of Anhui who became ill on March 9 and is now in a critical condition.

     

    They all showed initial symptoms of fever and coughs which developed into severe pneumonia and difficult breathing in later stages, according to the report.

     

    On Saturday, the three cases were confirmed to be human infection with H7N9 avian influenza by an expert team summoned by the health and family planning commission, based on clinical observation, laboratory tests and epidemiological surveys.

     

    On Friday, the Chinese Center for Disease Control and Preservation separated the H7N9 bird flu virus from body samples of the patients.

     

    So far, the commission said, it is unclear how the three got infected, and no mutual infections were discovered among them. Besides, no abnormalities were detected among 88 of their close contacts.

     

    The subtype of H7N9 bird flu virus has not been contracted to human beings before. The virus shows no signs of being highly contagious among humans, according to the clinical observation on the cases' close contacts.

     

    However, as only three cases of human infection of H7N9 have been found, relatively little research has been done on it. The expert team is working to study the toxicity and human-infection capacity of the virus, according to the commission.

     

    There are no vaccines against the H7N9 bird flu virus either at home or abroad.

     

    And from Hong Kong’s Centre for Health Protection.

     

    Notification of three human cases of H7N9 in Shanghai and Anhui


    The Centre for Health Protection (CHP) of the Department of Health received notification from the National Health and Family Planning Commission (the Commission) today (March 31) concerning three confirmed human cases of influenza A (H7N9).

     

    A CHP spokesman said the two cases in Shanghai were two men aged 87 and 27, who passed away on March 4 and 10 respectively. As regards the case in Anhui, the 35-year-old female patient is now in critical condition.

     

    Laboratory tests on the three patients' specimens by the Mainland health authorities yielded a positive result for H7N9.

     

    According to the Commission, the 27-year-old man was a butcher while the 35-year-old woman had exposure history to poultry before the onset of symptoms. No epidemiological link between the three cases was identified. So far, no abnormality was detected among the 88 close contacts of three cases.

     

    The spokesman said that influenza A (H7) is a statutorily notifiable infectious disease in Hong Kong. The CHP is maintaining close liaison with the Mainland health authorities to obtain more information on the cases.

     

    "We will heighten our vigilance and continue to maintain stringent port health measures in connection with this development," the spokesman said.

     

    The spokesman reminded members of the public to remain vigilant against avian influenza infection and to observe the following measures:

    • Avoid direct contact with poultry and birds or their droppings; if contacts have been made, they should wash hands thoroughly with soap and water;
    • Poultry and eggs should be thoroughly cooked before eating;
    • Wash hands frequently;
    • Cover nose and mouth while sneezing or coughing, hold the spit with tissue and put it into covered dustbins;
    • Avoid crowded places and contact with sick people with fever;
    • Wear a mask when you have respiratory symptoms or need to take care of patients with fever; and
    • When you have fever and influenza-like illnesses during a trip or when coming back to Hong Kong, you should consult doctors promptly and reveal your travel history.

         For further information on avian influenza, please visit the CHP's website (www.chp.gov.hk).

    Ends/Sunday, March 31, 2013
    Issued at HKT 13:47
     

     

     

    I’ll be digging for more information on these cases today, but for now, FluTrackers has a rapidly growing thread on these developments.

    Saturday, March 30, 2013

    Updating Puerto Rico’s Dengue Outbreak

    image

    Credit Healthmap Dengue

     


    # 7042

     

     

    While mosquito activity is greatly suppressed across most of North America during the winter months, the same cannot be said for the tropics, where mosquitoes – and the diseases they carry – can thrive pretty much year round.


    In 2010 Puerto Rico saw its worst Dengue outbreak in years, with the number of new infections at one point reaching nearly a 1,000 a week (see red line in chart below).

     

    image

     

    This epidemic ended in December of 2010, but before it was quashed it had infected more than 21,000 people, killing 31 (see MMWR: Dengue Epidemic In Puerto Rico).

     

    The following year (2011) was an average or slightly below average year for Dengue in Puerto Rico, but by the middle of last summer (see Dengue Above Epidemic Threshold In Puerto Rico) dengue numbers began to rise in Puerto Rico.

     

    In October of 2012 Health Secretary Lorenzo Gonzalez of the Puerto Rico Health Department once again declared a Dengue epidemic on the island (PDF Link – in Spanish), stating that at least six people have died, two of them being children (see Puerto Rico Declares Dengue Epidemic).

     

    While mosquitoes exist year-round in Puerto Rico, the end of the rainy season (which normally runs April-Nov) usually signals a drop in their numbers.

     

    The number of Dengue cases reported over the past several months has dropped since the epidemic declaration in October, although they remain well above the epidemic threshold.

     

    Which brings us to the most recent (week 8) Dengue Surveillance report from the CDC.  (Note: Surveillance figures typically run about 3 weeks behind to give time to compile and analyze the numbers).

     

    image

     

    The good news is that, while more than 3,500 cases have been reported since the first of the year, no fatalities have been recorded in 2013.

    image

     

    There are 4 different serotypes of the Dengue Fever virus (Puerto Rico is reporting types DENV1 & DENV4), so a person can become infected several times over their lifetime. Usually, the first infection with a dengue virus results in the milder form of the illness, while more serious illness can occur with subsequent infections.

     

    With roughly 4 million residents and another 4 million annual visitors to Puerto Rico – 3,541 infections over the first two months of the year – while concerning - is still a small fraction of the exposed population.

     

    One of the worries is that visitors may carry Dengue back home with them, and `seed’ local mosquito populations with the virus. 

     

    The CDC’s MMWR in a report in May of 2010 on Locally Acquired Dengue in Key West, had this to say:

     

    Cases of dengue in returning U.S. travelers have increased steadily during the past 20 years (8). Dengue is now the leading cause of acute febrile illness in U.S. travelers returning from the Caribbean, South America, and Asia (9).

     

    Many of these travelers are still viremic upon return to the United States and potentially capable of introducing dengue virus into a community with competent mosquito vectors.

     

    In truth, it may take many such introductions of Dengue or Malaria to an area before the right combination of weather, insect vectors, and ongoing transmission occur to enable it to get a foothold in a community.

     

    Florida’s latest Arbovirus Surveillance report lists 19 cases of Imported Dengue thus far in 2013, with 7 of those originating from Puerto Rico:

     

    Imported Dengue: Nineteen cases of dengue with onset in 2013 have been reported in individuals with travel history to a dengue endemic country in the two weeks prior to onset. Countries of origin were: The Caribbean, Columbia (2), Dominican Republic (2), Haiti, Indonesia, Jamaica (3), Philippines, Puerto Rico (7), and Saint Martin. Counties reporting cases were: Brevard, Broward, Clay, Lee, Miami-Dade (6), Orange (5), Osceola, and Palm Beach (3). Three of the cases were reported in non-Florida residents.

     

    So far, no locally acquired Dengue has been reported in Florida this year.

     

    The odds of contracting Dengue, or other mosquito transmitted diseases, are actually pretty low.  

     

    But they are certainly not zero.

     

    With no vaccine, it makes sense to take reasonable precautions whenever you are around mosquitoes (and not just in Dengue endemic areas). Those who travel to, or live in areas where mosquitoes are present are reminded that to  follow the `5 D’s’:

    image

     

    The World Health Organization’s Dengue and Severe Dengue Fact Sheet highlights the following points about the disease.

    Key facts
    • Dengue is a mosquito-borne viral infection.
    • The infection causes flu-like illness, and occasionally develops into a potentially lethal complication called severe dengue.
    • The global incidence of dengue has grown dramatically in recent decades.
    • About half of the world's population is now at risk.
    • Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas.
    • Severe dengue is a leading cause of serious illness and death among children in some Asian and Latin American countries.
    • There is no specific treatment for dengue/ severe dengue, but early detection and access to proper medical care lowers fatality rates below 1%.
    • Dengue prevention and control solely depends on effective vector control measures.

    Friday, March 29, 2013

    WER: Update On Human Cases Of Influenza At Human-Animal Interface

     

    image


    # 7041

     

    This week the World Health Organization’s Weekly Epidemiological Record (WER) is devoted to a review of human infections by novel (swine & avian) flu viruses over the course of 2012. 

     

    The bulk of this epidemiological analysis focuses on the 32 lab-confirmed H5N1 cases reported last year, but attention is also paid to a pair of H7N3 last year in Mexico, and a spate of swine H1N1v, H1N2v, and H3N2v (variant) infections across North America, as well.

     

     

    The full report is called: 

     

    Update on human cases of influenza at the human–animal interface, 2012

    This report describes the epidemiology of the 32 laboratory-confirmed human infections with highly pathogenic avian influenza (H5N1) virus that were reported to WHO from 6 countries during 2012, and summarizes the information on other zoonotic influenza infections – A(H3N2) variant, A(H1N1), A(H1N2) and A(H7N3) – reported in 2012 in humans.

     

    Some highlights follow regarding the H5N1 virus (slightly reparagraphed for readability):

     

    The epidemiological curve of human cases follows the same seasonal pattern seen in previous years, with larger numbers of cases in the months December to March (Figure 1). This curve follows the seasonal curve  of reported outbreaks in poultry. Of the human cases for the year, 72% (23/32 cases) were reported in the first 3 months of 2012 (1 January to 31 March).

    image

    Distribution by age and sex

    In 2012, most cases occurred in children and young adults; 90% (29/32) were in people aged <40 years and 34% (11/32) in children aged <10 years. Cases ranged in age from 6 months to 45 years, with a median age of 18 years.

     

    The median age of reported cases has varied annually since 2009: 5 years of age in 2009, 25 years in 2010 and 13 years in 2011. The median age of cases in Egypt remained high for the third consecutive year.

     

    The median age in Egypt in 2009 was 3 years but rose to 27 years in 2010 and 21 years in 2011 and continued to increase in 2012 to 31 years. In 2012, Egypt reported fewer cases of H5N1 infection (11 cases) compared with previous years (39 cases in 2011, 29 cases in 2010, 39 cases in 2009).

     

    In the past few years, the trend in Indonesia has been towards progressively younger cases. In 2012, the median age was 12 years, up from 8 years in 2011, but considerably down  from 34 years in 2010 and 20 for 2005–2011. Indonesia also reported a relatively low number of human cases in 2012: 9 cases were reported in 2012, 12 cases in 2011, 9 cases in 2010 and 21 cases in 2009, compared with 55 cases reported in 2006.

     

    In 2012, equal numbers of male and female cases were reported overall, although this pattern was not uniform across countries or age groups. The sex difference was most prominent in Egypt where 82% (9/11) of cases were female. Data from all cases reported during 2003– 2012 show a similar 1:1.2 male:female ratio.

     

    Clinical outcome

    In 2012, the overall proportion of fatal cases among
    those reported was 62.5% (20/32), slightly higher thanin the previous 3 years (55% in 2011, 50% in 2010, 44% in 2009) but similar to the average of all cases reported to WHO since 2003 (59% [360/610]). The proportion of confirmed cases with fatal outcomes varied among countries and age groups. The proportion of fatal cases among those reported was 100% in Indonesia (9/9) and Cambodia (3/3), and 0 (0/3) in Bangladesh. Considerable differences were also found across age groups.

    While the number of confirmed human infections with the H5N1 virus have declined over the past several years, this report cautions:

    Although the proportion of reported fatal human cases remains high, the finding of 3 human cases in 2012 with mild infection reinforces concerns that many milder cases of infection occur undetected. Recent reviews of H5 seroprevalence studies found little evidence that large numbers of cases of H5N1 infection are missed.12, 13

     

    However, because of the variation in protocols and standards in the serological studies, as well as persistent questions about serological responses in exposed or infected humans, the frequency of subclinical infection or mild illness remains uncertain.

     

    It is also likely that some severe and fatal cases were not diagnosed and thus missed.

    The risks posed by the H5N1 virus, along with other emerging influenza viruses, remains very real.  In the discussion portion of this report, the authors write:

     

    Influenza viruses are unpredictable. Their constant evolving nature raises concerns that these viruses could adapt or reassort with other influenza viruses, thereby gaining potential to become more transmissible to or more pathogenic in humans.

     

    Continued monitoring of the occurrence of human infections with non-seasonal influenza viruses and ongoing characterization of the viruses to assess their pandemic risk are therefore critically important for public health.

     

    Close collaboration with animal health partners allows information regarding viruses circulating in animal populations and human populations worldwide to be shared to improve assessment of global influenza risks to health.

     

    WHO continues to stress the importance of global
    monitoring of influenza viruses and recommends all
    Member States to strengthen routine influenza surveillance. All human infections with non-seasonal influenza viruses should be reported to WHO under the International Health Regulations (2005).

    JPeds: Autism NOT Linked To Timing & Number Of Childhood Vaccines

    image

     

     

    # 7040

     

    Despite a lack of any credible scientific evidence to support the notion, many parents believe that the number and timing of recommended childhood vaccinations increase the risk of their child developing autism.

     

    This has become a hot button issue, and a centerpiece of the anti-vaccine movement’s rhetoric.

     

    While unlikely to appease hardcore anti-vaccine activists, hopefully most parents will be reassured by the following CDC study that appeared overnight in the Journal of Pediatrics

     

    Researchers found no relationship between the number, or timing, of childhood vaccines and the development of autism spectrum disorder.

     

    First stop, a press release/editorial, followed by links to the study in the Journal Pediatrics, and an NPR blog.

     

     

    The risk of autism is not increased by 'too many vaccines too soon'

    Cincinnati, OH, March 29, 2013 -- Although scientific evidence suggests that vaccines do not cause autism, approximately one-third of parents continue to express concern that they do; nearly 1 in 10 parents refuse or delay vaccinations because they believe it is safer than following the Centers for Disease Control and Prevention's (CDC) schedule.

     

    A primary concern is the number of vaccines administered, both on a single day and cumulatively over the first 2 years of life. In a new study scheduled for publication in The Journal of Pediatrics, researchers concluded that there is no association between receiving "too many vaccines too soon" and autism.

     

    Dr. Frank DeStefano and colleagues from the CDC and Abt Associates, Inc. analyzed data from 256 children with autism spectrum disorder (ASD) and 752 children without ASD (born from 1994-1999) from 3 managed care organizations. They looked at each child's cumulative exposure to antigens, the substances in vaccines that cause the body's immune system to produce antibodies to fight disease, and the maximum number of antigens each child received in a single day of vaccination.

     

    The researchers determined the total antigen numbers by adding the number of different antigens in all vaccines each child received in one day, as well as all vaccines each child received up to 2 years of age. The authors found that the total antigens from vaccines received by age 2 years, or the maximum number received on a single day, was the same between children with and without ASD. Furthermore, when comparing antigen numbers, no relationship was found when they evaluated the sub-categories of autistic disorder and ASD with regression.

     

    Although the current routine childhood vaccine schedule contains more vaccines than the schedule in the late 1990s, the maximum number of antigens that a child could be exposed to by 2 years of age in 2013 is 315, compared with several thousand in the late 1990s. Because different types of vaccines contain varying amounts of antigens, this research acknowledged that merely counting the number of vaccines received does not adequately account for how different vaccines and vaccine combinations stimulate the immune system. For example, the older whole cell pertussis vaccine causes the production of about 3000 different antibodies, whereas the newer acellular pertussis vaccine causes the production of 6 or fewer different antibodies.

     

    An infant's immune system is capable of responding to a large amount of immunologic stimuli and, from time of birth, infants are exposed to hundreds of viruses and countless antigens outside of vaccination. According to the authors, "The possibility that immunological stimulation from vaccines during the first 1 or 2 years of life could be related to the development of ASD is not well-supported by what is known about the neurobiology of ASDs." In 2004, a comprehensive review by the Institute of Medicine concluded that there is not a causal relationship between certain vaccine types and autism, and this study supports that conclusion.


    The study may be accessed in PDF form at:

     

    "Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism,"

    by Frank DeStefano, MD, MPH, Cristofer S. Price, ScM, and Eric S. Weintraub, MPH, appears in The Journal of Pediatrics (www.jpeds.com), DOI 10.1016/j.jpeds.2013.02.001, published by Elsevier.

     

    For more on all this, NPR’s Shots blog has the following report and audio story.

     

    Number Of Early Childhood Vaccines Not Linked To Autism

    by Jon Hamilton

    March 29, 2013 3:08 AM

    Listen to the Story

    MMWR: Coccidioidomycosis Rising

    Image of Arthroconidia of Coccidioides immitis

    Arthroconidia of Coccidioides immitis – Credit CDC

    # 7039

     

    Although viruses and bacteria garner most of the infectious disease headlines, mycotic diseases – caused by pathogenic fungi – produce their fair share of morbidity and mortality across the United States each year as well.

     

    NOTE: While it makes sense to wear a mask in certain high exposure scenarios, environmental fungal spores are ubiquitous, and for the most part there really isn’t very much any of us can do to prevent exposure .

     

    Fortunately, for most people, exposure to these fungi does not result in illness. While anyone can be infected, those who are immunocompromised are at considerably greater risk.

     

    Some percentage of those infected may experience a mild flu-like illness, while an even smaller percent may experience a more serious illness, which can result in pneumonia, soft tissue infections, and (rarely) death.

     

    Last October, in Four Fungal Foes, we looked at four common fungal diseases in North America - but briefly:

     

    Along the Ohio River Valley and across a good deal of the Southeastern United States people are exposed to  Histoplasma capsulatum, a fungus which is found in bird and bat droppings, that can cause Histoplasmosis.

     

    image

    Credit Wikipedia

     

    Similarly, Blastomycosis (aka Gilchrist's disease), which is caused by Blastomyces dermatitidis - found in decaying leaves and grass – is widely spread across much of the eastern half of the country. 

     

    And in 1999 a tropical fungus called Cryptococcus gattii  (a yeast, really) appeared on Vancouver Island. Spread by the wind, it has expanded its range into Washington and Oregon.

     

    C. gattii infection remains rare in the United States, with only about 100 cases diagnosed between 2004 –2011, mostly from Oregon and Washington (cite).

     

    In 2010 the CDC’s Journal of Emerging Infectious Diseases published a research article on the spread of C. gattii  in British Columbia (Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007). 

     

    Additional fungal pathogens of concern include:

    Aspergillosis, Candidiasis, Dermatophytes, Exserohilium, Fungal Keratitis, Mucormycosis, Pneumocystis pneumonia, Sporotrichosis and others – all of which fall under the purview of the CDC’s Division of Bacterial and Mycotic Diseases, Mycotic Diseases Branch.

     


    But among all of the environmental fungal infections across the United States, the rising star appears to be coccidioidomycosis.

     

    As a native Floridian, I confess I’d never heard of Coccidioidomycosis until I moved to Phoenix in 1975 to work as a paramedic.

     

    Upon my arrival I received a `Welcome to Arizona’ indoctrination that reviewed such local scenarios as as scorpion stings, Gila Monster bites, bubonic plague, sand storms, and `Valley Fever’ . . . aka Coccidioidomycosis.

     

    Coccidioidomycosis is caused by the inhalation of spores from one of two soil borne fungi - Coccidioides immitis or C. posadasii - both commonly found in the American Southwest.

     

    Their spores can remain dormant in the desert soil for years, only to become airborne when the earth is disturbed by farming, earthquakes, construction, or windstorms.

     

    Most of the people who live in regions where these fungi are endemic are eventually exposed and either develop brief asymptomatic infections or mild flu-like symptoms. 

     

    image

    Credit Wikipedia

     

    Last fall I highlighted the CDC’s Valley Fever site , which calls `cocci’ a `silent epidemic’, and links to a series of outside investigative reports called “Just One Breath” by the Reporting on Health Collaborative.

     

    A Silent Epidemic

     

    Most cases of valley fever in the US occur in people who live in or have traveled to the southwestern United States, especially Arizona and California.

    It Only Takes One Breath

     

    Areas Where Valley Fever is Endemic

     

    Anyone can get valley fever, including children. However, it is most common among older adults, particularly those 60 and older. People who have recently moved to an area where the disease naturally occurs are at higher risk for infection.

     

    Several groups of people are at higher risk for developing the severe forms of valley fever, including:

      • African Americans

      • Asians

      • Women in their 3rd trimester of pregnancy

      • People with weak immune systems, including those with an organ transplant or who have HIV/AIDS

       

      Yesterday, the CDC’s MMWR carried a report on the skyrocketing rise in Coccidioidomycosis across the American Southwest between 1998 and 2011.

       

      The incidence of detected infection has increased 8-fold over that time, going from 5.4 per 100,000 population in 1998 to 42.6 in 2011.

       

      Some of this increase may well be `artifactual’, as coccidioidomycosis became a `legally reportable’ disease in Arizona in 1997 and protocols for testing, reporting, and surveillance have improved over the years.

       

      But better reporting is unlikely to account for this much of an increase.

       

      First stop, the MMWR report, followed by a link to the CDC press release, and then finally, a 30 minute video from the Arizona Department of Health Services (AZDHS) on `Valley Fever’.

       

      March 29, 2013 / Vol. 62 / No. 12
      CE Available


      Increase in Reported Coccidioidomycosis — United States, 1998–2011

      Coccidioidomycosis, also known as valley fever, can be costly and debilitating, with nearly 75% of patients missing work or school because of their illness, and approximately 40% requiring hospitalization. Previous publications have reported state-specific increases in coccidioidomycosis in Arizona and California during 1998–2001 and 2000–2007, respectively. To characterize long-term national trends, CDC analyzed data from the National Notifiable Diseases Surveillance System for the period 1998–2011. This report describes the results of that analysis

      (Continue . . .)

       

      From the CDC’s Newsroom.

       

      Valley Fever Increasing in Some Southwestern States

      Valley Fever, a fungal respiratory infection, dramatically increased in several southwestern states from 1998 through 2011, according to a new study by the Centers for Disease Control and Prevention. Cases in Arizona, California, Nevada, New Mexico and Utah rose from 2,265 in 1998 to more than 22,000 in 2011.

       

      Valley Fever (Coccidioidomycosis) is caused by inhaling a fungus called Coccidioides, which lives in the soil in the southwestern United States. Not everyone who is exposed to the fungus gets sick, but those who do typically have flu-like symptoms that can last for weeks or months. More than 40 percent of patients who get ill from Valley Fever may require hospitalization at some point, with an average cost of nearly $50,000 per hospital visit. Previous studies have shown that, of those who get sick, nearly 75 percent miss work or school – for approximately two weeks.

       

      "Valley Fever is causing real health problems for many people living in the southwestern United States," said CDC Director Tom Frieden, M.D., M.P.H. "Because fungus particles spread through the air, it’s nearly impossible to completely avoid exposure to this fungus in these hardest-hit states. It’s important that people be aware of Valley Fever if they live in or have travelled to the southwest United States."

       

      This recent increase in Valley Fever could be related to changes in weather, which could impact where the fungus grows and how much of it is circulating; higher numbers of new residents; or changes in the way the disease is detected and reported to the states or CDC. More research is needed to understand why the number of reported cases of Valley Fever has increased. Between 1998 and 2011, Arizona and California had average increases in Valley Fever incidence of 16 and 13 percent per year, respectively. The CDC has provided grants to these two states to study Valley Fever.
      During this time period, nearly 112,000 cases of Valley Fever were reported from 28 states and Washington, D.C., but 66 percent of cases were in Arizona, 31 percent were in California, 1 percent were in Nevada, New Mexico, and Utah, and about 1 percent were in all other states combined.

       

      "It’s difficult to say what’s causing the increase," said Benjamin J. Park, M.D., chief epidemiologist with CDC’s Mycotic Diseases Branch. "This is a serious and costly disease and more research is needed on how to reduce its effects."

      (Continue . . .)

       

      For a more local perspective, the AZDHS has a 3-part video called `Valley Fever: The Impact On Arizonans’, produced in 2008.

       

       

      Part 2 & 3 are available at the following links.

      9:03 VF-Web-Part-2.wmv

      9:22 VF-Web-Part-3.wmv

       

      And lastly, Robert Roos of CIDRAP NEWS has coverage of this story from last night, called:


      CDC: Valley fever cases in US Southwest rising fast

      Thursday, March 28, 2013

      CDC Update & Infographic On Fungal Meningitis Case

       

      image

       

      # 7038

       

      While not commanding the headlines that it did six months ago, the health impacts from last summer’s contaminated injectable steroids continue (see MMWR: Multistate Outbreak Of Fungal Meningitis). 

      Since the recall was announced in late September, we’ve learned of more than 50 deaths, nearly 700 still battling infections, with thousands more exposed and potentially still vulnerable to infection.

       

      The latest updates from the CDC (March 25th) are provided below, along with an infographic/timeline of the outbreak.

       

      image 

      CDC continues to receive reports of patients presenting with paraspinal/spinal infections (e.g., epidural abscess, phlegmon, discitis, vertebral osteomyelitis, or arachnoiditis at or near the site of injection). These syndromes have occurred in patients with and without evidence of fungal meningitis.

       

      Because these infections are distinct from meningitis and joint infections, CDC will report case counts, as below, to better describe types of infections being identified in patients exposed to a preservative-free methylprednisolone acetate (MPA) injection, with preservative-free MPA that definitely or likely came from one of the following three lots produced by the New England Compounding Center (NECC) [05212012@68, 06292012@26, 08102012@51].

      image 

      The infographic below provides a good overview of the outbreak.

       

      fungal-meningitis.

      Sisyphus And The Media

       

        image

      Credit Wikipedia



      # 7037

       

       

      Coming as it has on the 10th anniversary of the SARS epidemic of 2003, the recent spate of novel coronavirus cases originating from the Arabian peninsula have prompted inevitable media comparisons with that infamous outbreak of a decade ago.

       

      Both illnesses are, admittedly, caused by novel coronaviruses, have caused serious morbidity and mortality, and both appear to be of zoonotic origin.

       

      For headline writers and journalists looking for an easily understandable and reasonably descriptive term, `SARS-Like’ is an attractive appellation.


      But the World Health Organization has been quick to point out that such comparisons are both premature and potentially misleading. 

       

      Six weeks ago in, WHO: Please Don’t Call It `SARS-Like’, we looked at efforts by WHO’s Gregory Härtl on Twitter to convince the media, journalists, and bloggers not to use the term `SARS-Like’ when describing this emerging virus.

       

      Based on the headlines over the past 24 hours (examples below) this campaign doesn’t appear to have gained much traction.

       

       

      SARS-Like Virus Kills Two More People in Germany and Britain

      By SYDNEY LUPKIN (@slupkin)

      March 27, 2013

      The mysterious SARS-like virus that appears to be originating in the Middle East has claimed two more victims after people died from the infection in Germany and in Britain.

      Emirati dies in Germany from Sars-like virus infection

      Kyle Sinclair

      Mar 27, 2013 Updated Mar 27, 2013 10.55am

      An Emirati man has died in Germany after contracting a new form of a virus similar to Sars.

      Emirati man infected with new SARS-linked virus dies in German hospital

      By Associated Press, Published: March 26

      BERLIN — A man from the United Arab Emirates who was infected with a new SARS-related virus has died in Munich, German authorities said Tuesday.

       

      Despite attempts to rebrand it, `Swine Flu’ is still widely used in headlines around the globe to indicate the 2009 H1N1 virus. While public health officials may prefer the term NCoV, getting the media (and public) to stop saying `SARS-like’ is going to be difficult.



      Admittedly, I use NCoV in this blog and will continue to do so (at least until a better name comes along).  But I have an advantage that the mainstream media does not.

       

      My readers are – for the most part – astute followers of infectious disease and are already familiar with the term NCoV.

       

      For the newspaper headline writer, or journalist, asking them to substitute a term that perhaps 10% of the public recognizes for one that 90% already are familiar with is, frankly, an awfully hard sell.

       

      Of course, comparisons between the SARS virus and this emerging coronavirus go far beyond simply using the term `SARS-like’

       

      Yesterday, in a widely distributed newspaper article, the South China Morning Post carried a story called:

       

      New coronavirus appears deadlier than Sars, says HKU

      Mysterious coronavirus, though not less infectious, has a higher mortality rate and infects many species, Hong Kong researchers find

       


      Using qualifiers like `if it mutated further’ and `it could be more virulent than [SARS], this article – not unlike others we’ve seen - paints a worrisome, albeit speculative picture of this emerging virus.

       

      The trouble is, our knowledge of this virus remains very limited.

       

      We don’t know what animal species serves as its reservoir, how or why it is spilling over into humans, how many people have already contracted it, how it spreads from one human to the next, and how pathogenic it really is.

       

      Which overnight led  Gregory Härtl to remind the media, and others via Twitter, that it is really too soon to make informed predictions regarding this virus.

       

      image

       

      While these points are well taken, the difficulty is – nearly a year after the first outbreak (Jordan in April 2012) – we know disturbingly little about this virus.  

       

      The information coming out of the Middle East appears often to be delayed by days or even weeks, and has been noticeably lacking in detail.  

       

      The media abhors a vacuum, and with a voracious news cycle, will use whatever information is available to fill the void.  While perhaps less than helpful from a public relations standpoint, media speculation over the threat this virus poses is certainly not beyond the pale.

       

      I’m certain memories of the early tabloidization of the 2009 H1N1 pandemic still weigh heavily on public health officials around the world.

       

      It raised the public’s expectations for seeing a severe pandemic, and then left many believing that governments and health officials `cried wolf’.

       

      So, while I fully appreciate and sympathize on the desire to `set the record straight’, it truly is a Sisyphean task. Attempts to substitute - `It’s too soon to speculate’as a meme, have a low probability of success.

       

      The only `cure’ for these types of stories is more and better information on this virus.

       

      And that can only come about through the complete cooperation and transparency of those countries where this virus currently resides.

       

      Something the WHO is actively seeking, as evidenced by the following requests included in recent WHO NCoV updates:

       

      Based on the current situation and available information, WHO encourages all Member States (MS) to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns. WHO is currently working with international experts and countries where cases have been reported to assess the situation and review recommendations for surveillance and monitoring.

       

      All MS are reminded to promptly assess and notify WHO of any new case of infection with nCoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course.

      Wednesday, March 27, 2013

      ECDC: Epidemiological Update On NCoV

      Coronavirus

      Photo Credit NIAID

       

      # 7036

       

       

       

      The ECDC has released a new epidemiological update (the last was on Feb 22nd) on the novel coronavirus this morning, with details on four new cases reported ince that time. 

       

      They have also published  an updated table of all 17 cases available HERE.

       

       

       

      Epidemiological update: additional confirmed cases of novel coronavirus including sixth case diagnosed in Europe

      27 Mar 2013

      Epidemiological update: additional confirmed cases of novel coronavirus including sixth case diagnosed in Europe

      ECDC

      Since the ECDC epidemiological update of 22 February 2013, four new confirmed cases of novel coronavirus (nCoV) infection have been reported worldwide, totalling 17 cases and including eleven deaths. Three of the four recent cases have been reported by the Ministry of Health of Saudi Arabia to WHO on:

      • 6 March 2013: a 69 year old male, with no recent history of travel or contact with a confirmed case, hospitalised on 10 February 2013 and who died on 19 February [1].
      • 12 March 2013: a 39 year old male reported to have developed symptoms on 24 February and who died on 2 March while hospitalised. Potential exposures are under investigation [2].
      • 23 March 2013: a patient with mild symptoms diagnosed with nCoV infection and hospitalised, who has since recovered. The mode and source of transmission has not been identified, but the case is known to be a contact of the above case reported on 12 March [3].

      The fourth case was reported on 25 March by Robert Koch Institute (RKI), Germany, and is the second imported case to be reported in this EU Member State. The patient, a 73 year old male with underlying clinical conditions, had been hospitalised in United Arab Emirates and transferred to a hospital in Germany for specific clinical care where subsequent diagnosis of nCoV infection was confirmed. Despite intensive care treatment the patient died on 26 March [4]. Contact tracing and investigations are underway by German public health authorities.

       

      Since the start of reporting, six cases have been diagnosed and cared for in Europe (Table 1). Three cases (2 in Germany and 1 in UK) came to Europe as part of transfer for care from countries in the Arabian Peninsula where they acquired their infection.  A fourth case became unwell while in the Arabian Peninsula, but may have acquired his infection in either Pakistan or the Arabian Peninsula, before travelling to the UK. Extensive contact tracing has been undertaken around the first two UK cases and first German case, by respective national public health authorities [5-7]. To date, this has revealed two cases occurring though human-to-human transmission in the UK. Testing of other persons as recommended by WHO and ECDC has not revealed additional cases [5-9].

       

      Though the number of nCoV infections has increased this last month, most reported cases continue to be associated with the Arabian Peninsula, where contact tracing and epidemiological investigations by Public Health Authorities continue in order to identify the possible source of infection.

       

      The ECDC update of the rapid risk assessment for the EU provided on 19 February and its recommendations remain valid [10]. ECDC has published today a Public Health Development highlighting recent updated surveillance and clinical guidance from WHO and providing ECDC advice in their application by EU Member States [11,12].

      (Continue . . .)

       

      Nature: H5N1 viral-engineering dangers will not go away

       

      image

      BSL-4 Lab Worker - Photo Credit –USAMRIID

       

      # 7035

       

       

      Despite the ending of the H5N1 research moratorium in January (see Scientists Declare End To H5N1 Research Moratorium), the heated debate over biosecurity risks surrounding `Gain of Function’ (GOF) and Dual Use Of Research Concern (DURC) have not abated.

       

      Concerns were raised initially after the 2011 ESWI Influenza Conference in Malta, where Dutch researcher Ron Fouchier revealed that he’d created a more `transmissible’ form of the H5N1 virus (see Debra MacKenzie’s New Scientist: Five Easy Mutations)

       

      That discovery, along with similar news coming from Yoshihiro Kawaoka, a highly respected virologist at the University of Wisconsin-Madison School of Veterinary Medicine, set alarm bells ringing in the biosecurity community.

       

      In a commentary sure to raise the ire of a number of flu researchers - outspoken critic Simon Wain-Hobson, Professor of virology at the Pasteur Institute in Paris – argues in the Journal Nature that":

       

       

      `H5N1 GOF work — indeed all virological GOF work — should be suspended until virologists open up and engage in public discussion of their work and the issues it raises.’

       

       

      Follow the link below to read:

       

      H5N1 viral-engineering dangers will not go away

      Governments, funders and regulatory authorities must urgently address the risks posed by gain-of-function research, says Simon Wain-Hobson.

      Update On Mt. Hekla

       

      image

      Mt. Hekla Webcam

       

       

      # 7034

       

      Over the past 24 hours a blog that I wrote back in 2011 (Watching Mt. Hekla) has received a number of fresh hits, primarily because Iceland’s massive volcano has shown signs of stirring over the past couple of days.

       

      This 1,491 meter (4,892 ft) stratovolcano is located in the south of Iceland, and has seen at least 20 eruptions since the year 874, some of them massive and going on for months. 

       

      Mt. Hekla is located not far from the far-more-difficult-to-pronounce – Eyjafjallajökull - whose eruptions in April and May of 2010 closed down air traffic over parts of Europe and caused considerable economic impact.

       


      Mt. Hekla last erupted in the year 2000. 

       

      According to a pair of reports appearing in Iceland Review Online  since yesterday, seismic activity has forced local officials to declare a `level of uncertainty’ regarding this volcano.

       

      First, yesterday morning:

       

      March 26 | Possible Eruption in South Iceland’s Hekla Volcano

      hekla_psThe civil protection department has declared a level of uncertainty because of seismic activity in the volcano Hekla in South Iceland as announced by the National Commissioner of the Icelandic Police and chief of police in Hvolsvöllur shortly after 11 am this morning. more

      And then later in the day:

      Daily News

      March 26 | No Update on Hekla, Situation to be Reevaluated Tomorrow

      hekla_march_2013_psThere are no observable signs that an eruption of Hekla volcano is imminent and no updates have been issued. The civil protection department will tomorrow reevaluate the level of uncertainty declared today.  more

       

       

      For a far more expert assessment on the threat posed by Mt. Hekla, I would refer you to Erik Klemetti’s excellent Wired Science Eruptions blog.

       

       

      Alert Status Raised at Iceland’s Hekla


      Erik also blogged on the renewed activity in the Canary Islands yesterday as well:

       

      Earthquakes, Inflation Suggest New Magma Intruding Under El Hierro

       

       

      As of this writing, there are no clear indications that either of these volcanoes are on the verge of producing a major eruption.

       

      Their seismic activity bears watching, however.

       


      While volcanic eruptions are normally a localized (albeit often destructive and traumatic) event, sometimes they can have global impact. 

       

      When Mount Pinatubo erupted in the Philippines in 1991, within a year its aerosol cloud had dispersed around the globe, resulting in `an overall cooling of perhaps as large as -0.4°C over large parts of the Earth in 1992-93’ (see USGS The Atmospheric Impact of the 1991 Mount Pinatubo Eruption).

       

      Just over a year ago, in UK: Civil Threat Risk Assessment, we looked at a short list of disaster scenarios (man-made & natural) that the Cabinet Office believe to be genuine threats to the United Kingdom.

       

      image

       

      Among these is the impact from a major volcanic eruption.

       

      You may be wondering about the inclusion of a Volcanic threat to a country that isn’t exactly known for its volcanoes. Their concern stems from the impact of volcanic eruptions outside of their country – notably, in Iceland. Specifically they cite:

       

      Severe effusive (gas-rich) volcanic eruptions abroad – The 2010 eruption of the Eyjafjallajökull volcano in Iceland showed some of the consequences that a volcanic eruption abroad can have on the UK and its citizens. Following consultation with geological and meteorological experts about the potential risks the UK faces from volcanic eruptions in Iceland or elsewhere, the assessment is that there are two main kinds of risk from volcanic eruptions. The irst is an ash-emitting eruption, similar to that in 2010. The second, which is slightly less likely than an ash-emitting eruption, but which could have widespread impacts on health, agriculture and transport, is an effusive-style eruption on the scale of the 1783–84 Laki eruption in Iceland. This second type of eruption is now one of the highest priority risks in the NRA and the NRR.

      In 1783 the Craters of Laki in Iceland erupted and over the next 8 months spewed clouds of clouds of deadly hydrofluoric acid & Sulphur Dioxide, killing over half of Iceland’s livestock and roughly 25% of their human population.

       

      These noxious clouds drifted over Europe, and resulted in widespread crop failures and thousands of deaths from direct exposure to these fumes. There are also anecdotal reports that suggest this eruption had short-term global climate impacts as well.

       

      Another eruption of the type and scale seen in 1783 – while unlikely - could present an enormous disaster scenario not only to the UK, but to all of Europe.

       

      Natural disasters, like disease epidemics, can have regional and even global impacts.

       

      Reason enough to monitor these types of threats, no matter where in the world they may be, and to be prepared to deal with whatever might come your way.

       

      In the United States, while Alaska and Hawaii are well known for their volcanic activity, it may surprise many Americans to learn that the United States has 169 `active’ volcanoes within its borders, with about 40 of those in the `lower 48’ states.

       

      Washington is one of those states with a large number of volcanoes, and so May has been proclaimed Volcano Awareness Month.

       

      image


      This week happens to be Tsunami Preparedness Week in the United States - and while truly destructive tsunamis are rare - FEMA and NOAA take these threats seriously.

       

      image

       

      For more on  disaster preparedness, I would invite you to visit Ready.gov, FEMA,  or revisit these blogs:

       

      In An Emergency, Who Has Your Back?

      An Appropriate Level Of Preparedness

      The Gift of Preparedness 2012